VOZME Trademark

Trademark Overview

On Thursday, October 28, 2021, a trademark application was filed for VOZME with the United States Patent and Trademark Office. The USPTO has given the VOZME trademark a serial number of 97096659. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 15, 2024. This trademark is owned by Vertex Pharmaceuticals Incorporated. The VOZME trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of blood disorders; Pharmaceutical preparations primarily comprising cells for the treatment of sickle cell disease; Pharmaceutical preparations primarily comprising cells for the treatment of beta thalassemia
vozme

General Information

Serial Number97096659
Word MarkVOZME
Filing DateThursday, October 28, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 18, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of blood disorders; Pharmaceutical preparations primarily comprising cells for the treatment of sickle cell disease; Pharmaceutical preparations primarily comprising cells for the treatment of beta thalassemia
Translation of Words in MarkThe English translation of "VOZME" in the mark is "LET US TRANSPORT".

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 15, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVertex Pharmaceuticals Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02210
Party NameVertex Pharmaceuticals Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Trademark Events

Event DateEvent Description
Monday, November 1, 2021NEW APPLICATION ENTERED
Tuesday, November 9, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, April 10, 2022TEAS VOLUNTARY AMENDMENT RECEIVED
Sunday, April 10, 2022TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Monday, August 8, 2022ASSIGNED TO EXAMINER
Monday, August 15, 2022REMOVED FROM TEAS PLUS
Monday, August 15, 2022NON-FINAL ACTION WRITTEN
Monday, August 15, 2022NON-FINAL ACTION E-MAILED
Monday, August 15, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, August 19, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 19, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, August 19, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 19, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 23, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 23, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 24, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 12, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 28, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 18, 2022PUBLISHED FOR OPPOSITION
Tuesday, October 18, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 13, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, May 1, 2023SOU TEAS EXTENSION RECEIVED
Monday, May 1, 2023SOU EXTENSION 1 FILED
Monday, May 1, 2023SOU EXTENSION 1 GRANTED
Wednesday, May 3, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 13, 2023SOU TEAS EXTENSION RECEIVED
Monday, November 13, 2023SOU EXTENSION 2 FILED
Monday, November 13, 2023SOU EXTENSION 2 GRANTED
Wednesday, November 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 15, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, July 15, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

vozme pharmaceutical treatment preparations cells primarily comprising beta thalassemia disease cell